Incontinence Articles A-Z
Female incontinence is the inability for a woman to hold her urine until she gets to a toilet. This eMedTV article discusses incontinence in women in detail.
Female incontinence treatment options include: lifestyle changes, medications, devices, surgery, or other options. This eMedTV article discusses the different treatment options for women with incontinence.
Detrol is not available in generic form at this time. This article on the eMedTV Web site further discusses when generic Detrol may become available and explains the difference between a generic drug and its "generic name."
Generic Detrol LA is not expected to become available until September 2012, at the earliest. This eMedTV page lists factors that may delay the drug's availability and explains the difference between a generic version of a drug and its "generic name."
Generic Ditropan, which is sold as oxybutynin chloride, is available in tablet and syrup form. This page on the eMedTV Web site describes the various strengths and forms available and lists drug companies that currently manufacture generic Ditropan.
Ditropan XL is currently available in brand-name and generic form. As this part of the eMedTV Web site explains, generic Ditropan XL is sold by the name oxybutynin chloride extended-release and is available in three different strengths.
The earliest possible date that generic Enablex could become available is March 2010. This eMedTV resource discusses the possible dangers of buying so-called "generic Enablex" and explains the difference between a generic drug and its generic name.
Oxytrol is currently under a patent that prevents companies from making any generic versions of the drug. As this eMedTV article explains, as soon as the patent expires in April 2020, other drug companies can begin producing generic Oxytrol products.
Sanctura is currently protected by a patent that prevents any generic forms from being manufactured. As this eMedTV resource explains, as soon as this patent expires in May 2009, several companies are expected to start producing generic Sanctura.
A patent currently prevents any generic Sanctura XR (trospium XR) from being manufactured in the U.S. As this eMedTV article explains, this patent expires in August 2010, at which point a generic Sanctura XR may become available.
The earliest possible date that generic VESIcare will be available is December 2015. As this eMedTV article explains, many companies currently claim to sell "generic VESIcare," but these drugs may be fake, substandard, and potentially dangerous.
Incontinence in children is common. This eMedTV article discusses incontinence in children and links to other articles about urinary incontinence.
Kegel exercises strengthen the muscles that hold the bladder and many other organs in place. This eMedTV article discusses Kegel exercises in detail.